Science Explorer Back to mapMap

Most cited papers from EuBiologics (South Korea)

What are the most cited papers from EuBiologics (South Korea)?

The most cited paper from EuBiologics (South Korea) is "Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion" (Jongoh Shin, Jung‐Ran Noh, Dong‐Ho Chang et al., 2019), with 119 citations. Next come "Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis" (102) and "The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships" (86).

Showing 50 of 73 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Elucidation of Akkermansia muciniphila Probiotic Traits Driven by Mucin Depletion Jongoh Shin, Jung‐Ran Noh, Dong‐Ho Chang et al. · Frontiers in Microbiology Open access 22 May 2019 119
2 Secreted Akkermansia muciniphila threonyl-tRNA synthetase functions to monitor and modulate immune homeostasis Su‐Man Kim et al. · Cell Host & Microbe Open access Jun 2023 102
3 The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships Lina Odevall, Deborah Y. Q. Hong, Laura C. Digilio et al. · Vaccine Open access Oct 2018 86
4 A randomized, non-inferiority trial comparing two bivalent killed, whole cell, oral cholera vaccines (Euvichol vs Shanchol) in the Philippines Yeong Ok Baik, Seuk Keun Choi, Remigio M. Olveda et al. · Vaccine 5 Sep 2015 67
5 Emerging manufacturers engagements in the COVID −19 vaccine research, development and supply Sonia R. Pagliusi, Stephen Jarrett, Benoit Hayman et al. · Vaccine Open access 11 Jun 2020 60
6 Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi et al. · BMC Medicine Open access 30 Nov 2022 40
7 MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour‐suppressive activity Hyeonhee Lee, Bum‐Chan Park, Jong Soon Kang et al. · Cell Proliferation Open access 24 Jul 2020 35
8 Anti-Melanogenic and Antioxidant Effects of Cell-Free Supernatant from Lactobacillus gasseri BNR17 Sol Lee, Han-Oh Park, Wonbeak Yoo · Microorganisms Open access 8 Apr 2022 30
9 Pasteurized Akkermansia muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial Chang-Ho Kang, Eun-Soo Jung, Su‐Jin Jung et al. · Nutrients Open access 26 Nov 2024 29
10 Agathobaculum butyriciproducens Shows Neuroprotective Effects in a 6-OHDA-Induced Mouse Model of Parkinson’s Disease Da Woon Lee, Young‐Kyoung Ryu, Dong‐Ho Chang et al. · Journal of Microbiology and Biotechnology Open access 5 Sep 2022 26
11 Heminiphilus faecis gen. nov., sp. nov., a member of the family Muribaculaceae, isolated from mouse faeces and emended description of the genus Muribaculum Jun‐Kyu Park, Dong‐Ho Chang, Moon-Soo Rhee et al. · Antonie van Leeuwenhoek 10 Feb 2021 25
12 Safety and Immunogenicity Assessment of an Oral Cholera Vaccine through Phase I Clinical Trial in Korea Yeong Ok Baik, Seuk Keun Choi, Jae Woo Kim et al. · Journal of Korean Medical Science Open access 2014 24
13 The importance of vaccine stockpiling to respond to epidemics and remediate global supply shortages affecting immunization: strategic challenges and risks identified by manufacturers Stephen Jarrett, Sonia R. Pagliusi, Rachel Park et al. · Vaccine X Open access 22 Oct 2021 22
14 Quality Improvement of Capsular Polysaccharide in Streptococcus pneumoniae by Purification Process Optimization Chankyu Lee, Hee Jin Chun, Min‐Chul Park et al. · Frontiers in Bioengineering and Biotechnology Open access 4 Feb 2020 22
15 Development of a lateral flow immuno-chromatic strip assay for the detection of nervous necrosis virus (NNV, RGNNV genotype) K.U. Shyam, Ha-Na Jeong, Myung‐Joo Oh et al. · Aquaculture 9 Jan 2020 22
16 Agathobaculum butyriciproducens improves ageing-associated cognitive impairment in mice Jun Go, So-Young Maeng, Dong‐Ho Chang et al. · Life Sciences Open access 12 Jan 2024 21
17 Antibody-based lateral flow chromatographic assays for detecting fish and shrimp pathogens: A technical review K.U. Shyam, Hwi-Jin Kim, Sajal Kole et al. · Aquaculture 13 May 2022 21
18 Efficacy of novel bispecific antibody targeting TNF-α/CXCL10 in the treatment of experimental arthritis Shin Eui Kang, Jin Kyun Park, Hyun Jung Yoo et al. · Translational research 14 Jan 2021 21
19 Morinda citrifolia Leaf Extract Enhances Osteogenic Differentiation Through Activation of Wnt/ β -Catenin Signaling Hanna Gu, Kanitsak Boonanantanasarn, Moonkyu Kang et al. · Journal of Medicinal Food 5 Oct 2017 21
20 One-year antibody durability induced by EuCorVac-19, a liposome-displayed COVID-19 receptor binding domain subunit vaccine, in healthy Korean subjects Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik et al. · International Journal of Infectious Diseases Open access 7 Nov 2023 20
21 Metabolic engineering of Escherichia coli to produce a monophosphoryl lipid A adjuvant Yuhyun Ji, Jinsu An, Dohyeon Hwang et al. · Metabolic Engineering Open access 28 Nov 2019 20
22 Significance of Soluble CD93 in Type 2 Diabetes as a Biomarker for Diabetic Nephropathy: Integrated Results from Human and Rodent Studies Minyoung Lee, Ho Seon Park, Min Yeong Choi et al. · Journal of Clinical Medicine Open access 8 May 2020 19
23 Challenges and opportunities in developing a Shigella-containing combination vaccine for children in low- and middle-income countries: Report of an expert convening Mark S. Riddle, August Louis Bourgeois, Allison Clifford et al. · Vaccine Open access 15 Mar 2023 18
24 The Effect of Lactobacillus gasseri BNR17 on Postmenopausal Symptoms in Ovariectomized Rats Sol Lee, Dong Hoon Jung, Miri Park et al. · Journal of Microbiology and Biotechnology Open access 28 Jul 2021 18
25 Interim safety and immunogenicity analysis of the EuCorVac‐19 COVID‐19 vaccine in a Phase 3 randomized, observer‐blind, immunobridging trial in the Philippines Jonathan F. Lovell, Kazutoyo Miura, Yeong Ok Baik et al. · Journal of Medical Virology Open access Sep 2024 17
26 Safety and immunogenicity of the Euvichol-S oral cholera vaccine for prevention of Vibrio cholerae O1 infection in Nepal: an observer-blind, active-controlled, randomised, non-inferiority, phase 3 trial Katerina Rok Song et al. · The Lancet Global Health Open access 11 Apr 2024 14
27 Scalable production and immunogenicity of a cholera conjugate vaccine Suhi Jeon et al. · Vaccine Open access 27 Oct 2021 14
28 Measurement of Antibodies to Varicella-Zoster Virus Using a Virus-Free Fluorescent-Antibody-to-Membrane-Antigen (FAMA) Test Rackhyun Park, Ji Young Hwang, Kang Il Lee et al. · Journal of Microbiology and Biotechnology Open access 28 Feb 2015 11
29 An open-label, comparative, single dose, clinical Phase Ⅰ study to assess the safety and immunogenicity of typhoid conjugate vaccine (Vi-CRM197) in healthy Filipino adults Seuk Keun Choi, Yeong Ok Baik, Chan Wha Kim et al. · Vaccine 13 Apr 2021 10
30 Development and validation of a lateral flow immunochromatographic assay for specific detection of viral hemorrhagic septicemia virus (VHSV, genotype IVa) in olive flounder (Paralichthys olivaceus) Kyoung‐Hui Kong, Ha-Na Jeong, K.U. Shyam et al. · Aquaculture 9 Feb 2021 10
31 Development of a new 15-valent pneumococcal conjugate vaccine (PCV15) and evaluation of its immunogenicity Chankyu Lee, Seuk Keun Choi, Rock Ki Kim et al. · Biologicals 13 Aug 2019 10
32 Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc‐fused interleukin‐1 receptor antagonist, in healthy subjects: A first‐in‐human study Jaeseong Oh, Ki Young Huh, Young‐Gyu Cho et al. · British Journal of Clinical Pharmacology Open access 28 Oct 2019 9
33 A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines Paola Gageiro Pinto Russo, Antonio D. Ligsay, Remigio M. Olveda et al. · Vaccine Open access 9 Jun 2018 9
34 Development of a lateral flow immunochromatographic assay (LFIA) for the detection of hirame novirhabdovirus (HIRRV) in olive flounder (Paralichthys olivaceus) K.U. Shyam, Kyoung‐Hui Kong, Myung‐Joo Oh et al. · Aquaculture 10 Feb 2023 8
35 Reduction of free polysaccharide contamination in the production of a 15-valent pneumococcal conjugate vaccine Yoon Hee Whang, Soo Kyung Kim, Hyeseon Yoon et al. · PLoS ONE Open access 10 Dec 2020 7
36 A bispecific soluble receptor fusion protein that targets TNF‐α and IL‐21 for synergistic therapy in inflammatory arthritis Jin‐Sil Park, Seok‐Ho Yoo, Mi‐Ae Lim et al. · The FASEB Journal 21 Nov 2019 7
37 Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model Eun Young Lee, Sena Lee, Semi Rho et al. · Clinical and Experimental Vaccine Research Open access 2018 7
38 Loliolide in Sargassum horneri Alleviates Ultrafine Urban Particulate Matter (PM 0.1)-Induced Inflammation in Human RPE Cells Eun Jeoung Lee, Sol Lee, Hyun‐Jae Jang et al. · International Journal of Molecular Sciences Open access 21 Dec 2023 6
39 A Phase II/III, Multicenter, Observer-blinded, Randomized, Non-inferiority and Safety, study of typhoid conjugate vaccine (EuTCV) compared to Typbar-TCV® in healthy 6 Months-45 years aged participants Yeong Ok Baik, Youngjin Lee, Chankyu Lee et al. · Vaccine 9 Feb 2023 6
40 Antifungal activity of pinosylvin fromPinus densifloraon turfgrass fungal diseases Dong Gu Lee, Seong Jun Lee, Joyce P. Rodriguez et al. · Journal of Applied Biological Chemistry Open access 26 Sep 2017 6
41 A 6-Week Oral Toxicity Study of Oral Cholera Vaccine in Sprague-Dawley Rats Yeong-Ok Baek, Seuk-Keun Choi, Seo‐Ho Shin et al. · Toxicological Research Open access 31 Dec 2012 6
42 A randomized study to evaluate the safety and immunogenicity of a pentavalent meningococcal vaccine Yoonjin Kim, Sungyeun Bae, Kyung‐Sang Yu et al. · npj Vaccines Open access 7 Aug 2024 5
43 Vaccine traceability: Key learnings from the supply chain initiative by manufacturers from emerging countries Sonia R. Pagliusi, Yvette Madrid, Yudha Bramanti et al. · Vaccine X Open access 4 Aug 2023 5
44 Production of Plant-Derived Japanese Encephalitis Virus Multi-Epitope Peptide in Nicotiana benthamiana and Immunological Response in Mice Jae‐Wan Jung, Pil‐Gu Park, Won‐Kyung Lee et al. · International Journal of Molecular Sciences Open access 19 Jul 2023 5
45 30-Minute Highly Multiplexed VaxArray Immunoassay for Pneumococcal Vaccine Antigen Characterization Tianjing Hu, David F. Miller, Amber W. Taylor et al. · Vaccines Open access 19 Nov 2022 5
46 Development of an antibody-like T-cell engager based on VH-VL heterodimer formation and its application in cancer therapy Seil Jang, Jaeho Song, Nayoung Kim et al. · Biomaterials Open access 20 Mar 2021 5
47 E. coli-Produced Monophosphoryl Lipid a Significantly Enhances Protective Immunity of Pandemic H1N1 Vaccine Quyen Thi Nguyen, Eun‐Jin Kim, Jihyun Yang et al. · Vaccines Open access 16 Jun 2020 5
48 WHO implementation workshop on guidelines on procedures and data requirements for changes to approved biotherapeutic products, Seoul, Republic of Korea, 25–26 June 2019 Meenu Wadhwa et al. · Biologicals 17 Jan 2020 5
49 Generation of a human monoclonal antibody to cross-reactive material 197 (CRM197) and development of a sandwich ELISA for CRM197 conjugate vaccines Dain Kim, Hyeseon Yoon, Sangkyu Kim et al. · Journal of Microbiology and Biotechnology Open access 28 Dec 2018 5
50 Protective Effect of Delta-Like 1 Homolog Against Muscular Atrophy in a Mouse Model Ji Young Lee, Minyoung Lee, Dong-Hee Lee et al. · Endocrinology and Metabolism Open access 29 Aug 2022 4

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.